Evidence for the Role of Peroxisome Proliferator-Activated Receptor-β/δ in the Development of Spinal Cord Injury

被引:42
|
作者
Paterniti, Irene [1 ]
Esposito, Emanuela [1 ,3 ]
Mazzon, Emanuela [1 ]
Galuppo, Maria [1 ]
Di Paola, Rosanna [3 ]
Bramanti, Placido [3 ]
Kapoor, Amar [2 ]
Thiemermann, Christoph [2 ]
Cuzzocrea, Salvatore [3 ]
机构
[1] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Torre Biol Policlin Univ, I-98100 Messina, Italy
[2] St Bartholomews & Royal London Sch Med & Dent, Ctr Expt Med Nephrol & Crit Care, William Harvey Res Inst, London, England
[3] Ctr Neurolesi Bonino Pulejo, Inst Ricovero & Cura Carattere Sci, Messina, Italy
关键词
CYTOKINE PRODUCTION; IN-VIVO; MECHANISMS; APOPTOSIS; LIPOPOLYSACCHARIDE; DIFFERENTIATION; INFLAMMATION; EXPRESSION; LIGANDS; ATHEROSCLEROSIS;
D O I
10.1124/jpet.110.165605
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several lines of evidence suggest a biological role for peroxisome proliferator-activated receptor (PPAR)-beta/delta in the pathogenesis many diseases. The aim of the present study was to evaluate the contribution of PPAR-beta/delta in the secondary damage in experimental spinal cord injury (SCI) in mice. To this purpose, we used 4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy]acetic acid (GW0742), a high-affinity PPAR-beta/delta agonist. Spinal cord trauma was induced by the application of vascular clips (force of 24 g) to the dura via a four-level T-5 to T-8 laminectomy. SCI in mice resulted in severe trauma characterized by edema, neutrophil infiltration, production of inflammatory mediators, tissue damage, and apoptosis. GW0742 treatment (0.3 mg kg(-1) i.p.) 1 and 6 h after the SCI significantly reduced 1) the degree of spinal cord inflammation and tissue injury (histological score), 2) neutrophil infiltration (myeloperoxidase activity), 3) nitrotyrosine formation, 4) proinflammatory cytokines expression, 5) nuclear factor-kappa B activation, 6) inducible nitric-oxide synthase expression, and 6) apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling staining, FasL, Bax, and Bcl-2 expression). Moreover, GW0742 significantly ameliorated the recovery of limb function (evaluated by motor recovery score). To elucidate whether the protective effects of GW0742 are related to activation of the PPAR-beta/delta receptor, we also investigated the effect of PPAR-beta/delta antagonist methyl-3-({[2-(methoxy)-4-phenyl]amino}sulfonyl)-2-thiophenecarboxylate (GSK0660) on the protective effects of GW0742. GSK0660 (1 mg/kg i.p. 30 min before treatment with GW0742) significantly blocked the effect of the PPAR-beta/delta agonist and thus abolished the protective effect. Our results clearly demonstrate that GW0742 treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma.
引用
收藏
页码:465 / 477
页数:13
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor-γ in macrophage lipid homeostasis
    Lee, CH
    Evans, RM
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (08): : 331 - 335
  • [42] Is peroxisome proliferator-activated receptor-γ a new "Pal" of renin?
    Weatherford, Eric T.
    Itani, Hana
    Keen, Henry L.
    Sigmund, Curt D.
    HYPERTENSION, 2007, 50 (05) : 844 - 846
  • [43] Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation
    Toral, Marta
    Romero, Miguel
    Perez-Vizcaino, Francisco
    Duarte, Juan
    Jimenez, Rosario
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 312 (02): : H189 - H200
  • [44] Peroxisome proliferator-activated receptor-γ:: from adipogenesis to carcinogenesis
    Fajas, L
    Debril, MB
    Auwerx, J
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2001, 27 (01) : 1 - 9
  • [45] Ligands of the peroxisome proliferator-activated receptor-γ and heart failure
    Thiemermann, C
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (01) : 1 - 3
  • [46] Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis
    Liu, Huang-Jun
    Liao, Hai-Han
    Yang, Zheng
    Tang, Qi-Zhu
    PPAR RESEARCH, 2016, 2016
  • [47] Peroxisome proliferator-activated receptor-δ attenuates colon carcinogenesis
    Harman, FS
    Nicol, CJ
    Marin, HE
    Ward, JM
    Gonzalez, FJ
    Peters, JM
    NATURE MEDICINE, 2004, 10 (05) : 481 - 483
  • [48] Peroxisome proliferator-activated receptor-γ-mediated effects in the vasculature
    Duan, Sheng Zhong
    Usher, Michael G.
    Mortensen, Richard M.
    CIRCULATION RESEARCH, 2008, 102 (03) : 283 - 294
  • [49] Peroxisome proliferator-activated receptor-γ:: a versatile metabolic regulator
    Rocchi, S
    Auwerx, J
    ANNALS OF MEDICINE, 1999, 31 (05) : 342 - 351
  • [50] Importance of peroxisome proliferator-activated receptor-γ in hepatic ischemia/reperfusion injury in mice
    Akahori, Takahiro
    Sho, Masayuki
    Hamada, Kaoru
    Suzaki, Yasue
    Kuzumoto, Yukiyasu
    Nomi, Takeo
    Nakamura, Shinji
    Enomoto, Koji
    Kanehiro, Hiromichi
    Nakajima, Yoshiyuki
    JOURNAL OF HEPATOLOGY, 2007, 47 (06) : 784 - 792